Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2

[1]  You-hong Cui,et al.  β-Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma. , 2013, Cancer research.

[2]  You-hong Cui,et al.  TGF-β1 enhances tumor-induced angiogenesis via JNK pathway and macrophage infiltration in an improved zebrafish embryo/xenograft glioma model. , 2013, International immunopharmacology.

[3]  Isabelle Salmon,et al.  A Simplified Approach for the Molecular Classification of Glioblastomas , 2012, PloS one.

[4]  Peng Zhang,et al.  Tumor-Associated Microglia/Macrophages Enhance the Invasion of Glioma Stem-like Cells via TGF-β1 Signaling Pathway , 2012, The Journal of Immunology.

[5]  M. Caraglia,et al.  Editorial [Hot Topic: Target Therapy in Brain Tumours and Metastases (Guest Editors: M. Caraglia and R. Addeo)] , 2012 .

[6]  Yu Zhao,et al.  Lipid metabolism enzyme 5-LOX and its metabolite LTB4 are capable of activating transcription factor NF-κB in hepatoma cells. , 2012, Biochemical and biophysical research communications.

[7]  C. Croce miRNAs in the spotlight: Understanding cancer gene dependency , 2011, Nature Medicine.

[8]  Danish Sayed,et al.  MicroRNAs in development and disease. , 2011, Physiological reviews.

[9]  Bin Wang,et al.  The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell‐mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling , 2011, The Journal of pathology.

[10]  X. Bian,et al.  Concise Review: Contribution of Cancer Stem Cells to Neovascularization , 2011, Stem cells.

[11]  Bin Wang,et al.  An Inhibitor of Arachidonate 5-Lipoxygenase, Nordy, Induces Differentiation and Inhibits Self-Renewal of Glioma Stem-Like Cells , 2011, Stem Cell Reviews and Reports.

[12]  R. Jain,et al.  PDGF-D Improves Drug Delivery and Efficacy via Vascular Normalization, But Promotes Lymphatic Metastasis by Activating CXCR4 in Breast Cancer , 2011, Clinical Cancer Research.

[13]  K. Kelnar,et al.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. , 2011, Nature medicine.

[14]  Ping Yf,et al.  Cancer stem cells switch on tumor neovascularization. , 2011 .

[15]  M. Cleary,et al.  The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression. , 2010, Cancer research.

[16]  Michael F. Clarke,et al.  Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.

[17]  S. Missailidis,et al.  Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis. , 2009, International immunopharmacology.

[18]  Andrew D Norden,et al.  Therapeutic strategies for inhibiting invasion in glioblastoma , 2009, Expert review of neurotherapeutics.

[19]  X. Bian,et al.  Enrichment of Cancer Stem Cells Based on Heterogeneity of Invasiveness , 2009, Stem Cell Reviews and Reports.

[20]  Fedor V. Karginov,et al.  The miR-17∼92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma , 2009, Proceedings of the National Academy of Sciences.

[21]  G. I. Gallicano,et al.  miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation. , 2009, Developmental biology.

[22]  D. Bartel MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[23]  F. Slack,et al.  MicroRNA in cancer prognosis. , 2008, The New England journal of medicine.

[24]  Agnieszka Bronisz,et al.  Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. , 2008, Cancer research.

[25]  X. Bian,et al.  Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G‐protein coupled formylpeptide receptor FPR , 2008, The Journal of pathology.

[26]  X. Bian,et al.  Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. , 2008, Cancer letters.

[27]  Claudia Petritsch,et al.  miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells , 2008 .

[28]  M. Westphal,et al.  Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria , 2008, Oncogene.

[29]  J. Mendell miRiad Roles for the miR-17-92 Cluster in Development and Disease , 2008, Cell.

[30]  W. Henderson,et al.  Mechanisms of disease: Leukotrienes , 2007 .

[31]  Sriram Krishnamoorthy,et al.  Lipoxygenase metabolism: roles in tumor progression and survival , 2007, Cancer and Metastasis Reviews.

[32]  J. M. Thomson,et al.  Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. , 2007, Developmental biology.

[33]  C. Heeschen,et al.  Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.

[34]  X. Bian,et al.  Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma , 2007, Modern Pathology.

[35]  X. Bian,et al.  Unique proteomic features induced by a potential antiglioma agent, Nordy (dl‐nordihydroguaiaretic acid), in glioma cells , 2008, Proteomics.

[36]  M. Berens,et al.  Molecular targets of glioma invasion , 2007, Cellular and Molecular Life Sciences.

[37]  A. Habenicht,et al.  What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? , 2006, International journal of cancer.

[38]  Harikrishna Nakshatri,et al.  CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis , 2006, Breast Cancer Research.

[39]  Anwar Hossain,et al.  Mir-17-5p Regulates Breast Cancer Cell Proliferation by Inhibiting Translation of AIB1 mRNA , 2006, Molecular and Cellular Biology.

[40]  C. Croce,et al.  MicroRNA-cancer connection: the beginning of a new tale. , 2006, Cancer research.

[41]  Tara L. Naylor,et al.  microRNAs exhibit high frequency genomic alterations in human cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[42]  X. Bian,et al.  Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells. , 2006, Biochemical and biophysical research communications.

[43]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[44]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Plasterk,et al.  MicroRNA function in animal development , 2005, FEBS letters.

[46]  G. Maira,et al.  Extensive modulation of a set of microRNAs in primary glioblastoma. , 2005, Biochemical and biophysical research communications.

[47]  K. Kosik,et al.  MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. , 2005, Cancer research.

[48]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[49]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[50]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[51]  F. Davis,et al.  Current epidemiological trends and surveillance issues in brain tumors , 2001, Expert review of anticancer therapy.

[52]  M. Fukuzawa,et al.  Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: association with tumor progression and clinical outcome. , 1998, Journal of pediatric surgery.

[53]  H. Shimada,et al.  Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. , 1996, Cancer research.

[54]  L. Liotta,et al.  Tumor cell invasion inhibited by TIMP-2. , 1991, Journal of the National Cancer Institute.

[55]  H. Shimada,et al.  Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. , 1991, Cancer research.

[56]  M. Caraglia,et al.  Editorial: target therapy in brain tumours and metastases. , 2012, Current cancer drug targets.

[57]  Y. Ping,et al.  Cancer stem cells switch on tumor neovascularization. , 2011, Current molecular medicine.

[58]  M. Cleary,et al.  The miR-1792 microRNA Polycistron Regulates MLL Leukemia Stem Cell Potential by Modulating p 21 Expression , 2010 .

[59]  J. Massagué,et al.  Beyond tumorigenesis: cancer stem cells in metastasis , 2007, Cell Research.

[60]  Zang Ai-hua,et al.  Stem Cells,Cancer and Cancer Stem Cells , 2005 .

[61]  E F Heineman,et al.  Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. , 1999, Journal of the National Cancer Institute.